APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Patch for Pain Relief

Compare research editions
View pricing & licenses

Selected research

Industry Research

Transdermal Patch for Pain Relief Industry Research Report 2026

2 January 2026131 pages

Choose your research edition.

Industry ResearchTransdermal Patch for Pain Relief Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Patch for Pain Relief Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Transdermal Patch for Pain Relief Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Patch for Pain Relief Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Patch for Pain Relief Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Transdermal Patch for Pain Relief market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Transdermal Patch for Pain Relief is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Transdermal Patch for Pain Relief is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Transdermal Patch for Pain Relief is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Transdermal Patch for Pain Relief include Teva, Sanofi, Johnson & Johnson, Pfizer, GSK, Viatris, Qizheng, Performance Health and Nichiban, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Transdermal Patch for Pain Relief market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Transdermal Patch for Pain Relief Market by Company

Teva

Sanofi

Johnson & Johnson

Pfizer

GSK

Viatris

Qizheng

Performance Health

Nichiban

Lingrui

Laboratoires Genevrier

IBSA Group

Huarun 999

Hisamitsu

Haw Par

Endo

BLUE-EMU

Transdermal Patch for Pain Relief Segment by Type

Peppermint Patch

Fentanyl Patch

Capsaicin Patch

Lidocaine Patch

Diclofenac Patch

Methyl Salicylate Patch

Indomethacin Patch

Other

Transdermal Patch for Pain Relief Segment by Application

OTC

Rx

Transdermal Patch for Pain Relief Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Patch for Pain Relief market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Patch for Pain Relief and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Patch for Pain Relief.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Transdermal Patch for Pain Relief manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Transdermal Patch for Pain Relief by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Transdermal Patch for Pain Relief in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Transdermal Patch for Pain Relief Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Transdermal Patch for Pain Relief Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Transdermal Patch for Pain Relief Sales Market Share by Manufacturers (2021-2026) Table 8. Global Transdermal Patch for Pain Relief Revenue of Manufacturers (2021-2026) Table 9. Global Transdermal Patch for Pain Relief Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Transdermal Patch for Pain Relief Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Transdermal Patch for Pain Relief Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Transdermal Patch for Pain Relief, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Transdermal Patch for Pain Relief, Product Type & Application Table 14. Global Transdermal Patch for Pain Relief Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Transdermal Patch for Pain Relief by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Teva Company Information Table 19. Teva Business Overview Table 20. Teva Transdermal Patch for Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Teva Transdermal Patch for Pain Relief Product Portfolio Table 22. Teva Recent Developments Table 23. Sanofi Company Information Table 24. Sanofi Business Overview Table 25. Sanofi Transdermal Patch for Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Sanofi Transdermal Patch for Pain Relief Product Portfolio Table 27. Sanofi Recent Developments Table 28. Johnson & Johnson Company Information Table 29. Johnson & Johnson Business Overview Table 30. Johnson & Johnson Transdermal Patch for Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Johnson & Johnson Transdermal Patch for Pain Relief Product Portfolio Table 32. Johnson & Johnson Recent Developments Table 33. Pfizer Company Information Table 34. Pfizer Business Overview Table 35. Pfizer Transdermal Patch for Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Pfizer Transdermal Patch for Pain Relief Product Portfolio Table 37. Pfizer Recent Developments Table 38. GSK Company Information Table 39. GSK Business Overview Table 40. GSK Transdermal Patch for Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. GSK Transdermal Patch for Pain Relief Product Portfolio Table 42. GSK Recent Developments Table 43. Viatris Company Information Table 44. Viatris Business Overview Table 45. Viatris Transdermal Patch for Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Viatris Transdermal Patch for Pain Relief Product Portfolio Table 47. Viatris Recent Developments Table 48. Qizheng Company Information Table 49. Qizheng Business Overview Table 50. Qizheng Transdermal Patch for Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Qizheng Transdermal Patch for Pain Relief Product Portfolio Table 52. Qizheng Recent Developments Table 53. Performance Health Company Information Table 54. Performance Health Business Overview Table 55. Performance Health Transdermal Patch for Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Performance Health Transdermal Patch for Pain Relief Product Portfolio Table 57. Performance Health Recent Developments Table 58. Nichiban Company Information Table 59. Nichiban Business Overview Table 60. Nichiban Transdermal Patch for Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Nichiban Transdermal Patch for Pain Relief Product Portfolio Table 62. Nichiban Recent Developments Table 63. Lingrui Company Information Table 64. Lingrui Business Overview Table 65. Lingrui Transdermal Patch for Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Lingrui Transdermal Patch for Pain Relief Product Portfolio Table 67. Lingrui Recent Developments Table 68. Laboratoires Genevrier Company Information Table 69. Laboratoires Genevrier Business Overview Table 70. Laboratoires Genevrier Transdermal Patch for Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Laboratoires Genevrier Transdermal Patch for Pain Relief Product Portfolio Table 72. Laboratoires Genevrier Recent Developments Table 73. IBSA Group Company Information Table 74. IBSA Group Business Overview Table 75. IBSA Group Transdermal Patch for Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. IBSA Group Transdermal Patch for Pain Relief Product Portfolio Table 77. IBSA Group Recent Developments Table 78. Huarun 999 Company Information Table 79. Huarun 999 Business Overview Table 80. Huarun 999 Transdermal Patch for Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Huarun 999 Transdermal Patch for Pain Relief Product Portfolio Table 82. Huarun 999 Recent Developments Table 83. Hisamitsu Company Information Table 84. Hisamitsu Business Overview Table 85. Hisamitsu Transdermal Patch for Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Hisamitsu Transdermal Patch for Pain Relief Product Portfolio Table 87. Hisamitsu Recent Developments Table 88. Haw Par Company Information Table 89. Haw Par Business Overview Table 90. Haw Par Transdermal Patch for Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Haw Par Transdermal Patch for Pain Relief Product Portfolio Table 92. Haw Par Recent Developments Table 93. Endo Company Information Table 94. Endo Business Overview Table 95. Endo Transdermal Patch for Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Endo Transdermal Patch for Pain Relief Product Portfolio Table 97. Endo Recent Developments Table 98. BLUE-EMU Company Information Table 99. BLUE-EMU Business Overview Table 100. BLUE-EMU Transdermal Patch for Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. BLUE-EMU Transdermal Patch for Pain Relief Product Portfolio Table 102. BLUE-EMU Recent Developments Table 103. Global Transdermal Patch for Pain Relief Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Transdermal Patch for Pain Relief Sales by Region (2021-2026) & (K Units) Table 105. Global Transdermal Patch for Pain Relief Sales Market Share by Region (2021-2026) Table 106. Global Transdermal Patch for Pain Relief Sales by Region (2027-2032) & (K Units) Table 107. Global Transdermal Patch for Pain Relief Sales Market Share by Region (2027-2032) Table 108. Global Transdermal Patch for Pain Relief Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Transdermal Patch for Pain Relief Revenue Market Share by Region (2021-2026) Table 110. Global Transdermal Patch for Pain Relief Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Transdermal Patch for Pain Relief Revenue Market Share by Region (2027-2032) Table 112. North America Transdermal Patch for Pain Relief Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Transdermal Patch for Pain Relief Sales by Country (2021-2026) & (K Units) Table 114. North America Transdermal Patch for Pain Relief Sales by Country (2027-2032) & (K Units) Table 115. North America Transdermal Patch for Pain Relief Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Transdermal Patch for Pain Relief Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Transdermal Patch for Pain Relief Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Transdermal Patch for Pain Relief Sales by Country (2021-2026) & (K Units) Table 119. Europe Transdermal Patch for Pain Relief Sales by Country (2027-2032) & (K Units) Table 120. Europe Transdermal Patch for Pain Relief Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Transdermal Patch for Pain Relief Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Transdermal Patch for Pain Relief Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Transdermal Patch for Pain Relief Sales by Country (2021-2026) & (K Units) Table 124. Asia Pacific Transdermal Patch for Pain Relief Sales by Country (2027-2032) & (K Units) Table 125. Asia Pacific Transdermal Patch for Pain Relief Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Transdermal Patch for Pain Relief Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Transdermal Patch for Pain Relief Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Transdermal Patch for Pain Relief Sales by Country (2021-2026) & (K Units) Table 129. South America Transdermal Patch for Pain Relief Sales by Country (2027-2032) & (K Units) Table 130. South America Transdermal Patch for Pain Relief Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Transdermal Patch for Pain Relief Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Transdermal Patch for Pain Relief Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Transdermal Patch for Pain Relief Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Transdermal Patch for Pain Relief Sales by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Transdermal Patch for Pain Relief Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Transdermal Patch for Pain Relief Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Transdermal Patch for Pain Relief Sales by Type (2021-2026) & (K Units) Table 138. Global Transdermal Patch for Pain Relief Sales by Type (2027-2032) & (K Units) Table 139. Global Transdermal Patch for Pain Relief Sales Market Share by Type (2021-2026) Table 140. Global Transdermal Patch for Pain Relief Sales Market Share by Type (2027-2032) Table 141. Global Transdermal Patch for Pain Relief Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Transdermal Patch for Pain Relief Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Transdermal Patch for Pain Relief Revenue Market Share by Type (2021-2026) Table 144. Global Transdermal Patch for Pain Relief Revenue Market Share by Type (2027-2032) Table 145. Global Transdermal Patch for Pain Relief Price by Type (2021-2026) & (US$/Unit) Table 146. Global Transdermal Patch for Pain Relief Price by Type (2027-2032) & (US$/Unit) Table 147. Global Transdermal Patch for Pain Relief Sales by Application (2021-2026) & (K Units) Table 148. Global Transdermal Patch for Pain Relief Sales by Application (2027-2032) & (K Units) Table 149. Global Transdermal Patch for Pain Relief Sales Market Share by Application (2021-2026) Table 150. Global Transdermal Patch for Pain Relief Sales Market Share by Application (2027-2032) Table 151. Global Transdermal Patch for Pain Relief Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Transdermal Patch for Pain Relief Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Transdermal Patch for Pain Relief Revenue Market Share by Application (2021-2026) Table 154. Global Transdermal Patch for Pain Relief Revenue Market Share by Application (2027-2032) Table 155. Global Transdermal Patch for Pain Relief Price by Application (2021-2026) & (US$/Unit) Table 156. Global Transdermal Patch for Pain Relief Price by Application (2027-2032) & (US$/Unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Transdermal Patch for Pain Relief Distributors List Table 160. Transdermal Patch for Pain Relief Customers List Table 161. Transdermal Patch for Pain Relief Industry Trends Table 162. Transdermal Patch for Pain Relief Industry Drivers Table 163. Transdermal Patch for Pain Relief Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Transdermal Patch for Pain Relief Product Image Figure 5. Global Transdermal Patch for Pain Relief Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Transdermal Patch for Pain Relief Market Size (2021-2032) & (US$ Million) Figure 7. Global Transdermal Patch for Pain Relief Sales (2021-2032) & (K Units) Figure 8. Global Transdermal Patch for Pain Relief Average Price (US$/Unit) & (2021-2032) Figure 9. Peppermint Patch Product Image Figure 10. Fentanyl Patch Product Image Figure 11. Capsaicin Patch Product Image Figure 12. Lidocaine Patch Product Image Figure 13. Diclofenac Patch Product Image Figure 14. Methyl Salicylate Patch Product Image Figure 15. Indomethacin Patch Product Image Figure 16. Other Product Image Figure 17. OTC Product Image Figure 18. Rx Product Image Figure 19. Global Transdermal Patch for Pain Relief Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Transdermal Patch for Pain Relief, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Transdermal Patch for Pain Relief Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Transdermal Patch for Pain Relief Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Transdermal Patch for Pain Relief Sales by Region in 2025 Figure 25. Global Transdermal Patch for Pain Relief Revenue by Region in 2025 Figure 26. North America Transdermal Patch for Pain Relief Market Size by Country in 2025 Figure 27. North America Transdermal Patch for Pain Relief Sales Market Share by Country (2021-2032) Figure 28. North America Transdermal Patch for Pain Relief Revenue Market Share by Country (2021-2032) Figure 29. United States Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Transdermal Patch for Pain Relief Market Size by Country in 2025 Figure 32. Europe Transdermal Patch for Pain Relief Sales Market Share by Country (2021-2032) Figure 33. Europe Transdermal Patch for Pain Relief Revenue Market Share by Country (2021-2032) Figure 34. Germany Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Transdermal Patch for Pain Relief Market Size by Country in 2025 Figure 40. Asia Pacific Transdermal Patch for Pain Relief Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Transdermal Patch for Pain Relief Revenue Market Share by Country (2021-2032) Figure 42. China Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. China Taiwan Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Transdermal Patch for Pain Relief Market Size by Country in 2025 Figure 51. South America Transdermal Patch for Pain Relief Sales Market Share by Country (2021-2032) Figure 52. South America Transdermal Patch for Pain Relief Revenue Market Share by Country (2021-2032) Figure 53. Mexico Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Brazil Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Transdermal Patch for Pain Relief Market Size by Country in 2025 Figure 57. Middle East and Africa Transdermal Patch for Pain Relief Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Transdermal Patch for Pain Relief Revenue Market Share by Country (2021-2032) Figure 59. Turkey Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. UAE Transdermal Patch for Pain Relief Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Global Transdermal Patch for Pain Relief Sales Market Share by Type (2021-2032) Figure 63. Global Transdermal Patch for Pain Relief Revenue Market Share by Type (2021-2032) Figure 64. Global Transdermal Patch for Pain Relief Price (US$/Unit) by Type (2021-2032) Figure 65. Global Transdermal Patch for Pain Relief Sales Market Share by Application (2021-2032) Figure 66. Global Transdermal Patch for Pain Relief Revenue Market Share by Application (2021-2032) Figure 67. Global Transdermal Patch for Pain Relief Price (US$/Unit) by Application (2021-2032) Figure 68. Transdermal Patch for Pain Relief Value Chain Figure 69. Transdermal Patch for Pain Relief Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Transdermal Patch for Pain Relief Industry Opportunities and Challenges

Scope & coverage.

Types
  • Peppermint Patch
  • Fentanyl Patch
  • Capsaicin Patch
  • Lidocaine Patch
  • Diclofenac Patch
  • Methyl Salicylate Patch
  • Indomethacin Patch
  • Other
Applications
  • OTC
  • Rx
Companies covered
  • Teva
  • Sanofi
  • Johnson & Johnson
  • Pfizer
  • GSK
  • Viatris
  • Qizheng
  • Performance Health
  • Nichiban
  • Lingrui
  • Laboratoires Genevrier
  • IBSA Group
  • Huarun 999
  • Hisamitsu
  • Haw Par
  • Endo
  • BLUE-EMU

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Transdermal Patch for Pain Relief Market Size (2021-2032)
  4. 2.2.2 Global Transdermal Patch for Pain Relief Sales (2021-2032)
  5. 2.2.3 Global Transdermal Patch for Pain Relief Market Average Price (2021-2032)
  6. 2.3 Transdermal Patch for Pain Relief by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Peppermint Patch
  9. 2.3.3 Fentanyl Patch
  10. 2.3.4 Capsaicin Patch
  11. 2.3.5 Lidocaine Patch
  12. 2.3.6 Diclofenac Patch
  13. 2.3.7 Methyl Salicylate Patch
  14. 2.3.8 Indomethacin Patch
  15. 2.3.9 Other
  16. 2.4 Transdermal Patch for Pain Relief by Application
  17. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  18. 2.4.2 OTC
  19. 2.4.3 Rx
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Transdermal Patch for Pain Relief Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Transdermal Patch for Pain Relief Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Transdermal Patch for Pain Relief Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Transdermal Patch for Pain Relief Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Transdermal Patch for Pain Relief Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Transdermal Patch for Pain Relief, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Transdermal Patch for Pain Relief, Product Type & Application
  8. 3.8 Global Manufacturers of Transdermal Patch for Pain Relief, Established Date
  9. 3.9 Global Transdermal Patch for Pain Relief Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Teva
  2. 4.1.1 Teva Company Information
  3. 4.1.2 Teva Business Overview
  4. 4.1.3 Teva Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Teva Transdermal Patch for Pain Relief Product Portfolio
  6. 4.1.5 Teva Recent Developments
  7. 4.2 Sanofi
  8. 4.2.1 Sanofi Company Information
  9. 4.2.2 Sanofi Business Overview
  10. 4.2.3 Sanofi Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sanofi Transdermal Patch for Pain Relief Product Portfolio
  12. 4.2.5 Sanofi Recent Developments
  13. 4.3 Johnson & Johnson
  14. 4.3.1 Johnson & Johnson Company Information
  15. 4.3.2 Johnson & Johnson Business Overview
  16. 4.3.3 Johnson & Johnson Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Johnson & Johnson Transdermal Patch for Pain Relief Product Portfolio
  18. 4.3.5 Johnson & Johnson Recent Developments
  19. 4.4 Pfizer
  20. 4.4.1 Pfizer Company Information
  21. 4.4.2 Pfizer Business Overview
  22. 4.4.3 Pfizer Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Pfizer Transdermal Patch for Pain Relief Product Portfolio
  24. 4.4.5 Pfizer Recent Developments
  25. 4.5 GSK
  26. 4.5.1 GSK Company Information
  27. 4.5.2 GSK Business Overview
  28. 4.5.3 GSK Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 GSK Transdermal Patch for Pain Relief Product Portfolio
  30. 4.5.5 GSK Recent Developments
  31. 4.6 Viatris
  32. 4.6.1 Viatris Company Information
  33. 4.6.2 Viatris Business Overview
  34. 4.6.3 Viatris Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Viatris Transdermal Patch for Pain Relief Product Portfolio
  36. 4.6.5 Viatris Recent Developments
  37. 4.7 Qizheng
  38. 4.7.1 Qizheng Company Information
  39. 4.7.2 Qizheng Business Overview
  40. 4.7.3 Qizheng Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Qizheng Transdermal Patch for Pain Relief Product Portfolio
  42. 4.7.5 Qizheng Recent Developments
  43. 4.8 Performance Health
  44. 4.8.1 Performance Health Company Information
  45. 4.8.2 Performance Health Business Overview
  46. 4.8.3 Performance Health Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Performance Health Transdermal Patch for Pain Relief Product Portfolio
  48. 4.8.5 Performance Health Recent Developments
  49. 4.9 Nichiban
  50. 4.9.1 Nichiban Company Information
  51. 4.9.2 Nichiban Business Overview
  52. 4.9.3 Nichiban Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Nichiban Transdermal Patch for Pain Relief Product Portfolio
  54. 4.9.5 Nichiban Recent Developments
  55. 4.10 Lingrui
  56. 4.10.1 Lingrui Company Information
  57. 4.10.2 Lingrui Business Overview
  58. 4.10.3 Lingrui Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Lingrui Transdermal Patch for Pain Relief Product Portfolio
  60. 4.10.5 Lingrui Recent Developments
  61. 4.11 Laboratoires Genevrier
  62. 4.11.1 Laboratoires Genevrier Company Information
  63. 4.11.2 Laboratoires Genevrier Business Overview
  64. 4.11.3 Laboratoires Genevrier Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Laboratoires Genevrier Transdermal Patch for Pain Relief Product Portfolio
  66. 4.11.5 Laboratoires Genevrier Recent Developments
  67. 4.12 IBSA Group
  68. 4.12.1 IBSA Group Company Information
  69. 4.12.2 IBSA Group Business Overview
  70. 4.12.3 IBSA Group Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 IBSA Group Transdermal Patch for Pain Relief Product Portfolio
  72. 4.12.5 IBSA Group Recent Developments
  73. 4.13 Huarun 999
  74. 4.13.1 Huarun 999 Company Information
  75. 4.13.2 Huarun 999 Business Overview
  76. 4.13.3 Huarun 999 Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Huarun 999 Transdermal Patch for Pain Relief Product Portfolio
  78. 4.13.5 Huarun 999 Recent Developments
  79. 4.14 Hisamitsu
  80. 4.14.1 Hisamitsu Company Information
  81. 4.14.2 Hisamitsu Business Overview
  82. 4.14.3 Hisamitsu Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Hisamitsu Transdermal Patch for Pain Relief Product Portfolio
  84. 4.14.5 Hisamitsu Recent Developments
  85. 4.15 Haw Par
  86. 4.15.1 Haw Par Company Information
  87. 4.15.2 Haw Par Business Overview
  88. 4.15.3 Haw Par Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Haw Par Transdermal Patch for Pain Relief Product Portfolio
  90. 4.15.5 Haw Par Recent Developments
  91. 4.16 Endo
  92. 4.16.1 Endo Company Information
  93. 4.16.2 Endo Business Overview
  94. 4.16.3 Endo Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Endo Transdermal Patch for Pain Relief Product Portfolio
  96. 4.16.5 Endo Recent Developments
  97. 4.17 BLUE-EMU
  98. 4.17.1 BLUE-EMU Company Information
  99. 4.17.2 BLUE-EMU Business Overview
  100. 4.17.3 BLUE-EMU Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 BLUE-EMU Transdermal Patch for Pain Relief Product Portfolio
  102. 4.17.5 BLUE-EMU Recent Developments
5 Global Transdermal Patch for Pain Relief Market Scenario by Region
  1. 5.1 Global Transdermal Patch for Pain Relief Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Transdermal Patch for Pain Relief Sales by Region: 2021-2032
  3. 5.2.1 Global Transdermal Patch for Pain Relief Sales by Region: 2021-2026
  4. 5.2.2 Global Transdermal Patch for Pain Relief Sales by Region: 2027-2032
  5. 5.3 Global Transdermal Patch for Pain Relief Revenue by Region: 2021-2032
  6. 5.3.1 Global Transdermal Patch for Pain Relief Revenue by Region: 2021-2026
  7. 5.3.2 Global Transdermal Patch for Pain Relief Revenue by Region: 2027-2032
  8. 5.4 North America Transdermal Patch for Pain Relief Market Facts & Figures by Country
  9. 5.4.1 North America Transdermal Patch for Pain Relief Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Transdermal Patch for Pain Relief Sales by Country (2021-2032)
  11. 5.4.3 North America Transdermal Patch for Pain Relief Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Transdermal Patch for Pain Relief Market Facts & Figures by Country
  15. 5.5.1 Europe Transdermal Patch for Pain Relief Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Transdermal Patch for Pain Relief Sales by Country (2021-2032)
  17. 5.5.3 Europe Transdermal Patch for Pain Relief Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Transdermal Patch for Pain Relief Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Transdermal Patch for Pain Relief Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Transdermal Patch for Pain Relief Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Transdermal Patch for Pain Relief Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Transdermal Patch for Pain Relief Market Facts & Figures by Country
  35. 5.7.1 South America Transdermal Patch for Pain Relief Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Transdermal Patch for Pain Relief Sales by Country (2021-2032)
  37. 5.7.3 South America Transdermal Patch for Pain Relief Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Transdermal Patch for Pain Relief Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Transdermal Patch for Pain Relief Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Transdermal Patch for Pain Relief Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Transdermal Patch for Pain Relief Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Transdermal Patch for Pain Relief Sales by Type (2021-2032)
  2. 6.1.1 Global Transdermal Patch for Pain Relief Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Transdermal Patch for Pain Relief Sales Market Share by Type (2021-2032)
  4. 6.2 Global Transdermal Patch for Pain Relief Revenue by Type (2021-2032)
  5. 6.2.1 Global Transdermal Patch for Pain Relief Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Transdermal Patch for Pain Relief Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Transdermal Patch for Pain Relief Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Transdermal Patch for Pain Relief Sales by Application (2021-2032)
  2. 7.1.1 Global Transdermal Patch for Pain Relief Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Transdermal Patch for Pain Relief Sales Market Share by Application (2021-2032)
  4. 7.2 Global Transdermal Patch for Pain Relief Revenue by Application (2021-2032)
  5. 7.2.1 Global Transdermal Patch for Pain Relief Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Transdermal Patch for Pain Relief Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Transdermal Patch for Pain Relief Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Transdermal Patch for Pain Relief Value Chain Analysis
  2. 8.1.1 Transdermal Patch for Pain Relief Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Transdermal Patch for Pain Relief Production Mode & Process
  5. 8.2 Transdermal Patch for Pain Relief Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Transdermal Patch for Pain Relief Distributors
  8. 8.2.3 Transdermal Patch for Pain Relief Customers
9 Global Transdermal Patch for Pain Relief Analyzing Market Dynamics
  1. 9.1 Transdermal Patch for Pain Relief Industry Trends
  2. 9.2 Transdermal Patch for Pain Relief Industry Drivers
  3. 9.3 Transdermal Patch for Pain Relief Industry Opportunities and Challenges
  4. 9.4 Transdermal Patch for Pain Relief Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst